Renin-angiotensin system gene polymorphisms and premature coronary heart disease

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 6, Issue 1, 2005, Pages 38-42

  Sekuri, Cevad ^a,e   Cam, F Sirri ^b   Ercan, Ertugrul ^c   Tengiz, Istemihan ^c   Sagcan, Abdi ^a   Eser, Erhan ^b   Berdeli, Afig ^d   Akin, Mustafa ^d  

^a KENT HOSPITAL   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

^c Central Hospital Izmir   (Turkey)

^d EGE UNIVERSITY   (Turkey)

^e NONE   (Turkey)

Author keywords

Cardiovascular risk factors; Gene polymorphism; Premature coronary heart disease; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING; TURKEY (REPUBLIC);

EID: 20444375456     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2005.005     Document Type: Article

References (29)

1. Turkish Heart Report. Publication of Turkish Society of Cardiology. Istanbul: Yenilik Press, 2000:11-25.
2. Griendling KK, Murphy TJ, Alexander WJ. Molecular biology of the renin-angiotensin system. Circulation 1993;87: 1816-28.
3. Schuh JR, Blehm DJ, Friedlich GE et al. Differential effect of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest 1993;91:1453-8.
4. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
5. Chobanian AV, Haudenschild CC, Nickerson C et al. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 1990;15:327-31.
6. Pfeffer MA, Braunwald E, Moye LA et al. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Engl J Med 1992;327:669-77.
7. Katsuya T, Koike G, Yee TW et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995;345:1600-03.
8. Tiret L, Bonnardeaux A, Poirier O et al. Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor DD genotype of the gene polymorphisms on risk of myocardial infarction. Lancet 1994;344:910-13.
9. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and Criteria for Diagnosis of Ischemic Heart Disease. Circulation 1979;59:607-08.
10. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
11. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl 1993;3:120-1.
12. Caulfield M, Lavander P, Farral M et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994;330:1629-33.
13. Alvarez R, Reguero JR, Batalla A et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc Res 1998; 40:375-9.
14. Hauser ER, Mooser V, Crossman DC et al. Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) Study. Am Heart J 2003;145:602-13.
15. Roncaglioni MC, Santoro L, D'Avanzo B et al. on behalf of GISSIEFRIM Investigators. Role of family history in patients with myocardial infarction: an Italian Case-Control study. Circulation 1992;85:2065-72.
16. Gardemann A, Fink M, Stricker J et al. ACE I:D gene polymorphism: presence of the ACE D allele increases the risk of coronary artery disease in younger individuals. Atherosclerosis 1998; 139:153-9.
17. Petrovic D, Zorc M, Kanic V, Peterlin B. Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction. Angiology 2001; 52:247-52.
18. Van Bockxmeer FM, Mamotte CDS, Burke V, Taylor RR. Angiotensin-converting enzyme gene polymorphism and premature coronary heart disease. Clin Sci 2000;99:247-51.
19. Ermis C, Tsai MY, Hanson NQ, Akar N, Aras O. Angiotensin I converting enzyme, angiotensin II type I receptor and angiotensinogen polymorphisms and early myocardial infarction in Turkish population. Thromb Haemost 2002;88;693-4.
20. Fatini C, Abbate R, Pepe G et al. Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur Heart J 2000; 21:633-8.
21. Batalla A, Alvarez R, Reguero JR et al. Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clin Chem 2000; 46:1910-15.
22. Ishigami T, Umemura S, Iwamoto T et al. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 1995;91:951-4.
23. Fernandez-Arcas N, Dieguez-Lucena JL, Munoz-Moran E et al. Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction. Clin Genet 2001; 60:52-7.
24. Atac FB, Akcay A, Ozdemir FN et al. Polymorphisms of angiotensin-converting enzyme, angiotensinogen, angiotensin II type 1 and type 2 receptors and endothelial nitric oxide synthase in Turkish renal transplant recipients: A preliminary study. Tissue Antigens 2002; 60:558.
25. Nakauchi Y, Suehiro T, Yamamoto M et al. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor. gene polymorphisms as risk factors for coronary heart disease. Atherosclerosis 1996;125:161-9.
26. Anvari A, Turel Z, Schmidt A et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphism in coronary disease and malignant ventricular arrhythmias. Cardiovasc Res 1999;43:879-83.
27. Steeds RP, Wardle A, Smith PD, Martin D, Channer KS, Samani NJ. Analysis of the postulated interaction between the angiotensin II sub-type 1 receptor gene A1166C polymorphism and the insertion: deletion polymorphism of the angiotensin converting enzyme gene on risk of myocardial infarction. Atherosclerosis 2001;154:123-8.
28. Berge KE, Bakken A, Bohn M, Erikssen J, Berg K. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction. Clin Genet 1997;52:71-6.
29. Tiret L, Bonnardeaux A, Poirier O et al. Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994;344:910-13.